Literature DB >> 17987785

Prenatal vitamin A deficiency causes laryngeal malformation in rats.

Ichiro Tateya1, Tomoko Tateya, Rebecca Lynn Surles, Sherry Tanumihardjo, Diane M Bless.   

Abstract

OBJECTIVES: Our previous research demonstrated that vitamin A might be related to vocal fold development. The purpose of this study was to determine whether vitamin A deficiency affects prenatal laryngeal development in rats.
METHODS: Two considerations were necessary in designing a study using a rat model: for embryonic survival, vitamin A is necessary through day 10 of gestation, and laryngeal formation occurs primarily after day 11. Thus, we created a rat model that developed vitamin A deficiency after embryonic day 11. Ten pregnant rats (5 vitamin A-deficient rats and 5 control rats) were studied. Embryos were collected at embryonic day 18.5 and analyzed histologically.
RESULTS: Eighteen percent of the vitamin A-deficient embryos were alive and demonstrated laryngotracheal cartilage malformation, incomplete separation of the glottis, and/or laryngoesophageal clefts.
CONCLUSIONS: These results document the important role played by vitamin A in laryngeal development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987785     DOI: 10.1177/000348940711601011

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

Review 1.  Characterization of vocal fold scar formation, prophylaxis, and treatment using animal models.

Authors:  Diane M Bless; Nathan V Welham
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-12       Impact factor: 2.064

2.  The effect of retinyl palmitate on healing of benign vocal fold lesions.

Authors:  Erdogan Okur; Orhan Kemal Kahveci; Abdullah Aycicek; Ali Altuntaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-26       Impact factor: 2.503

3.  Dynamics of vitamin A uptake, storage, and utilization in vocal fold mucosa.

Authors:  Kohei Nishimoto; Yutaka Toya; Christopher R Davis; Sherry A Tanumihardjo; Nathan V Welham
Journal:  Mol Metab       Date:  2020-05-28       Impact factor: 7.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.